Sérgio Alves

Experience

Country President - Portugal - AstraZeneca Jan 2021 - Present
- Leads the Portuguese affiliate of AstraZeneca, a dynamic organization of 200+ employees, focusing on innovative science and leadership in four therapy areas: Oncology; Cardiovascular, Renal and Metabolism; Respiratory & Immunology; Vaccines & Immune Therapies.

- Has full P&L accountability, with revenues above $100m/year.- Leads the Portuguese affiliate of AstraZeneca, a dynamic organization of 200+ employees, focusing on innovative science and leadership in four therapy areas: Oncology; Cardiovascular, Renal and Metabolism; Respiratory & Immunology; Vaccines & Immune Therapies. - Has full P&L accountability, with revenues above $100m/year

Pfizer 
- Senior Director - West Europe Sub-Cluster Lead - Hospital BusinessSenior Director - West Europe Sub-Cluster Lead - Hospital Business Dec 2018 - Dec 2020 
- Managed the new Hospital Business Unit of Pfizer's Biopharmaceuticals Group in the following West Europe mid-sized markets: Austria, Switzerland, Belgium, the Netherlands, Portugal, Ireland and Luxembourg.
- The new Hospital Business Unit portfolio included anti-infectives and sterile injectables; it was created to focus on the significant role of hospitals in healthcare systems.
- Had full P&L accountability- Managed the new Hospital Business Unit of Pfizer's Biopharmaceuticals Group in the following West Europe mid-sized markets: Austria, Switzerland, Belgium, the Netherlands, Portugal, Ireland and Luxembourg. - The new Hospital Business Unit portfolio included anti-infectives and sterile injectables; it was created to focus on the significant role of hospitals in healthcare systems. - Had full P&L accountability

- Senior Director - Country Lead, Austria - Pfizer Essential Health (PEH)Senior Director - Country Lead, Austria - Pfizer Essential Health (PEH)
Mar 2017 - Nov 2018 · 1 yr 9 mosMar 2017 - Nov 2018 · 1 yr 9 mos - Vienna, AustriaVienna, Austria
- Led the PEH (Pfizer Essential Health) Business Unit of Pfizer in Austria. This BU had 100+ products including 1- an Ambulatory portfolio with off-pattent iconic brands such as Lipitor, Lyrica and Viagra; 2- a large Hospital portfolio including new anti-infectives launched in 2017; 3- a Biosimilar portfolio.
- Had full P&L accountability, with revenues close to $100m.- Led the PEH (Pfizer Essential Health) Business Unit of Pfizer in Austria. This BU had 100+ products including 1- an Ambulatory portfolio with off-pattent iconic brands such as Lipitor, Lyrica and Viagra; 2- a large Hospital portfolio including new anti-infectives launched in 2017; 3- a Biosimilar portfolio. - Had full P&L accountability, with revenues close to $100m

- Senior Director - Regional Business Director, Europe - Pfizer Essential Health (PEH) Senior Director - Regional Business Director, Europe - Pfizer Essential Health (PEH)
Jul 2015 - Feb 2017 · 1 yr 8 mosJul 2015 - Feb 2017 · 1 yr 8 mos - Bratislava, SlovakiaBratislava, Slovakia
Responsible for delivering exceptional European business performance (with specific focus on the $4B Ambulatory business) by:
- Identifying, assessing and realizing broader commercial opportunities, and supporting to execute these in collaboration with the respective partners;
- Partnering with country organizations, provide support and guidance, and act as a key liaison with all respective functions at headquarters.
- Supporting country efforts to develop commercial capabilities aligned with the strategies and performance of GEP Europe.Responsible for delivering exceptional European business performance (with specific focus on the $4B Ambulatory business) by: - Identifying, assessing and realizing broader commercial opportunities, and supporting to execute these in collaboration with the respective partners; - Partnering with country organizations, provide support and guidance, and act as a key liaison with all respective functions at headquarters. - Supporting country efforts to develop commercial capabilities aligned with the strategies and performance of GEP Europe